Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Cancer Med ; 9(3): 1069-1078, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31568682

RESUMO

AIMS: Glioblastoma (GBM) is the most common and lethal malignant brain tumor in adults. Glioma stem cells (GSCs) are implicated in this poor prognosis and in radio(chemo-)resistance. We have previously demonstrated that among potentially highly specific GSC markers oligodendrocyte lineage transcription factor 2 (OLIG2) appears to be the most specific and cyclin D2 (CCND2) the only one related to cell cycle regulation. The purpose of this work was to investigate the clinical significance and the evolution of OLIG2 and CCND2 protein expression in GBM. METHODS AND RESULTS: Immunohistochemical expression analysis of Olig2 and Ccnd2 was carried out on a cohort of human paired GBM samples comparing initial resections with local recurrent tumors after radiation therapy (RT) alone or radio-chemotherapy with temozolomide (RT-TMZ). Uni- and multivariate logistic regression analysis revealed that significant risk factors predicting early mortality (<12 months) are: subtotal surgery for recurrence, time to recurrence <6 months, Ccnd2 nuclear expression at initial surgery ≥30%, and Olig2 nuclear expression <30% at second surgery after RT alone and RT-TMZ. CONCLUSIONS: We demonstrated that patients for whom nuclear expression of Olig2 becomes low (<30%) after adjuvant treatments have a significantly shorter time to recurrence and survival reflecting most probably a proneural to mesenchymal transition of the GSCs population. We also highlighted the fact that at initial surgery, high nuclear expression (≥30%) of CCND2, a G1/S regulator specific of GSCs, has a prognostic value and is associated with early mortality (<12 months).


Assuntos
Neoplasias Encefálicas/mortalidade , Ciclina D2/metabolismo , Glioblastoma/mortalidade , Recidiva Local de Neoplasia/terapia , Células-Tronco Neoplásicas/patologia , Fator de Transcrição 2 de Oligodendrócitos/metabolismo , Adulto , Idoso , Encéfalo/citologia , Encéfalo/patologia , Encéfalo/cirurgia , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/terapia , Núcleo Celular/patologia , Quimiorradioterapia Adjuvante/métodos , Ciclina D2/análise , Feminino , Glioblastoma/patologia , Glioblastoma/terapia , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/mortalidade , Recidiva Local de Neoplasia/patologia , Células-Tronco Neoplásicas/citologia , Fator de Transcrição 2 de Oligodendrócitos/análise , Prognóstico , Estudos Retrospectivos , Fatores de Risco , Análise de Sobrevida , Temozolomida/uso terapêutico , Fatores de Tempo , Resultado do Tratamento
2.
J Proteome Res ; 15(7): 2265-82, 2016 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-27193225

RESUMO

Alexander disease (AxD) is a neurodegenerative disorder characterized by astrocytic protein aggregates called Rosenthal fibers (RFs). We used mouse models of AxD to determine the protein composition of RFs to obtain information about disease mechanisms including the hypothesis that sequestration of proteins in RFs contributes to disease. A method was developed for RF enrichment, and analysis of the resulting fraction using isobaric tags for relative and absolute quantitation mass spectrometry identified 77 proteins not previously associated with RFs. Three of five proteins selected for follow-up were confirmed enriched in the RF fraction by immunobloting of both the AxD mouse models and human patients: receptor for activated protein C kinase 1 (RACK1), G1/S-specific cyclin D2, and ATP-dependent RNA helicase DDX3X. Immunohistochemistry validated cyclin D2 as a new RF component, but results for RACK1 and DDX3X were equivocal. None of these was decreased in the non-RF fractions compared to controls. A similar result was obtained for the previously known RF component, alphaB-crystallin, which had been a candidate for sequestration. Thus, no support was obtained for the sequestration hypothesis for AxD. Providing possible insight into disease progression, the association of several of the RF proteins with stress granules suggests a role for stress granules in the origin of RFs.


Assuntos
Doença de Alexander , Agregados Proteicos , Proteoma/análise , Animais , Astrócitos , Ciclina D2/análise , RNA Helicases DEAD-box/análise , Proteínas de Ligação ao GTP/análise , Humanos , Imuno-Histoquímica , Camundongos , Proteínas de Neoplasias/análise , Neuropeptídeos/análise , Agregação Patológica de Proteínas , RNA Helicases/análise , Receptores de Quinase C Ativada , Receptores de Superfície Celular/análise
3.
Oncol Res ; 18(2-3): 127-31, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20066902

RESUMO

The most recent studies emphasize a link between B-cell proliferation in vivo and clinical outcome of B-cell chronic lymphocytic leukemia (B-CLL). The expression of cyclin D2 in B-CLL cells isolated from the peripheral blood of 27 untreated patients in relation to the apoptosis ratio both before and 72 h after culture in the absence of growth factors was analyzed by immunocytochemistry. The significant associations between cell death in culture and both cyclin D2 expression in freshly isolated cells and the rate of its decrement in culture found in this study confirm the special role of cyclin D2 in enhancing the longevity of these cells in vivo. As cyclin D2 is inducible in the early G1 phase, its increased expression might also reflect the activation of cells attempting to replicate in vivo. Furthermore, the finding that B-CLL progression positively correlates with the gradual increase in the proportion of apoptotic B lymphocytes in culture seems to support the notion of cells striving to undergo division in the absence of growth factors. All together, these results indicate the possibility that cyclin D2+ cells represent a pool of leukemic cells with the potential to enter the dividing compartment.


Assuntos
Ciclina D2/fisiologia , Leucemia Linfocítica Crônica de Células B/patologia , ADP-Ribosil Ciclase 1/análise , Apoptose , Biomarcadores , Proliferação de Células , Ciclina D2/análise , Humanos , Glicoproteínas de Membrana/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA